Anne Mirabella

571 total citations
6 papers, 432 citations indexed

About

Anne Mirabella is a scholar working on Molecular Biology, Hematology and Cell Biology. According to data from OpenAlex, Anne Mirabella has authored 6 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Hematology and 1 paper in Cell Biology. Recurrent topics in Anne Mirabella's work include Ubiquitin and proteasome pathways (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Protein Degradation and Inhibitors (2 papers). Anne Mirabella is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Protein Degradation and Inhibitors (2 papers). Anne Mirabella collaborates with scholars based in United States, Netherlands and United Kingdom. Anne Mirabella's co-authors include Benjamin M. Foster, Till Bartke, Herman S. Overkleeft, Alexei F. Kisselev, Xiaoyang Zhang, Tian‐Li Wang, András Lánczky, Balázs Győrffy, Bogdan I. Florea and Mathieu Lupien and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Anne Mirabella

6 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Mirabella United States	5	354	158	53	52	51	6	432
Wassim Abdulrahman France	7	666 1.9×	183 1.2×	34 0.6×	45 0.9×	109 2.1×	9	722
Jasper E. Neggers United States	9	337 1.0×	98 0.6×	63 1.2×	39 0.8×	44 0.9×	12	410
Oscar W. Huang United States	8	566 1.6×	144 0.9×	42 0.8×	66 1.3×	37 0.7×	8	614
Frances Potjewyd United States	9	351 1.0×	79 0.5×	43 0.8×	24 0.5×	45 0.9×	14	428
Silvia Escudero United States	7	379 1.1×	201 1.3×	31 0.6×	89 1.7×	16 0.3×	8	489
Sung‐Bau Lee Taiwan	13	599 1.7×	205 1.3×	57 1.1×	52 1.0×	16 0.3×	25	727
Kathy A. Gelato Germany	14	739 2.1×	92 0.6×	51 1.0×	59 1.1×	135 2.6×	21	815
Ana P. G. Silva Australia	13	440 1.2×	64 0.4×	24 0.5×	66 1.3×	30 0.6×	22	546
Anthony B. Mak Canada	9	316 0.9×	187 1.2×	59 1.1×	36 0.7×	14 0.3×	13	450
Adán Pinto-Fernández United Kingdom	13	371 1.0×	109 0.7×	47 0.9×	30 0.6×	19 0.4×	27	492

Countries citing papers authored by Anne Mirabella

Since Specialization

Citations

This map shows the geographic impact of Anne Mirabella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Mirabella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Mirabella more than expected).

Fields of papers citing papers by Anne Mirabella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Mirabella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Mirabella. The network helps show where Anne Mirabella may publish in the future.

Co-authorship network of co-authors of Anne Mirabella

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Mirabella. A scholar is included among the top collaborators of Anne Mirabella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Mirabella. Anne Mirabella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Kraus, Marianne, Jürgen Bader, Paul P. Geurink, et al.. (2015). The novel 2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells. Haematologica. 100(10). 1350–1360. 41 indexed citations

2.

Mirabella, Anne, Benjamin M. Foster, & Till Bartke. (2015). Chromatin deregulation in disease. Chromosoma. 125(1). 75–93. 85 indexed citations

3.

Wilkins, Owen M., Sondra L. Downey-Kopyscinski, David A. Williams, et al.. (2014). Cell-line-specific high background in the Proteasome-Glo assay of proteasome trypsin-like activity. Analytical Biochemistry. 451. 1–3. 3 indexed citations

4.

Geurink, Paul P., Wouter A. van der Linden, Anne Mirabella, et al.. (2013). Incorporation of Non-natural Amino Acids Improves Cell Permeability and Potency of Specific Inhibitors of Proteasome Trypsin-like Sites. Journal of Medicinal Chemistry. 56(3). 1262–1275. 84 indexed citations

5.

Magnani, Luca, Alexander Stoeck, Xiaoyang Zhang, et al.. (2013). Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer. Proceedings of the National Academy of Sciences. 110(16). E1490–9. 123 indexed citations

6.

Mirabella, Anne, Alexandre A. Pletnev, Sondra L. Downey-Kopyscinski, et al.. (2011). Specific Cell-Permeable Inhibitor of Proteasome Trypsin-like Sites Selectively Sensitizes Myeloma Cells to Bortezomib and Carfilzomib. Chemistry & Biology. 18(5). 608–618. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact